Biotech · Private company
Tarix Pharmaceuticals
Track this companyFree. Adds Tarix Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- TXA127Phase 2 · Lymphoma, Non-HodgkinClinicalTrials.gov · fetched Nov 12, 2026
- TXA127 1000 mcg/kg/dayPhase 1 · Double Cord Blood TransplantClinicalTrials.gov · fetched Nov 12, 2026
- TXA127 300 mcg/kg/dayPhase 1 · Double Cord Blood TransplantClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaNA · ACTIVE_NOT_RECRUITING · started Apr 1, 2012ClinicalTrials.gov NCT01582204 · fetched Nov 12, 2026
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationPHASE1 · TERMINATED · started Jan 1, 2011ClinicalTrials.gov NCT01300611 · fetched Nov 12, 2026
- Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma PatientsPHASE2 · TERMINATED · started Jun 1, 2010ClinicalTrials.gov NCT01121120 · fetched Nov 12, 2026